RxDoctor Payments Data

Stephanie Cody, MD

Family Medicine · Little Rock, ARNPI 1275632903

Payments from drug & device makers

$2,450in general payments, 2019–2025

Across 142 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$291
  • Abbott$271
  • Idorsia Pharmaceuticals US Inc$225
  • Pfizer$224
  • Supernus Pharmaceuticals, Inc.$193
  • Takeda Pharmaceuticals U.S.A., Inc.$167
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$2,450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,450 in reported general payments places this provider in the 75th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$88,685
Medicare patients
257
Services billed
1,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$64,989
EliquisApixaban30$26,055
JanuviaSitagliptin Phosphate16$21,480
JardianceEmpagliflozin11$18,537
FarxigaDapagliflozin Propanediol12$18,168
LinzessLinaclotide18$14,131
TrulicityDulaglutide11$12,485
GemtesaVibegron16$11,345
MyrbetriqMirabegron13$5,690
Levothyroxine Sodium213$2,664
Irbesartan55$2,170
Levemir FlexpenInsulin Detemir11$2,038
Colchicine19$1,825
ValacyclovirValacyclovir Hcl31$1,785
Nebivolol Hcl23$1,750

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$64,98946 claims
PfizerEliquis$224$26,05530 claims
MerckJanuvia$93$21,48016 claims
AstraZenecaFarxiga$110$18,16812 claims
AbbVieLinzess$291$14,13118 claims
Lilly USA, LLCTrulicity$109$12,48511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →